ISRCTN10000341已完成未知
Anxiety and depression in Parkinson's Disease
niversity College London0 个研究点目标入组 350 人开始时间: 2021年12月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Participants must be judged by the investigator to have capacity to understand the nature, design, and procedures of the study and must be able to provide a signed and dated informed consent in accordance with Good Clinical Practice (GCP), International Conference on Harmonization (ICH), and local regulations. All subjects must be willing and able to comply with scheduled visits, required study procedures and laboratory tests.
- •2. Willing and able to provide written consent
- •3. All participants must have adequate visual and auditory acuity according to investigator’s judgement to complete the neuropsychological testing.
- •4. People with PD should have confirmed diagnosis of PD according to Movement Disorder Society Clinical Diagnostic Criteria and must have at least two of the following: resting tremor, bradykinesia, rigidity (must have either resting tremor or bradykinesia); OR either asymmetric resting tremor or asymmetric bradykinesia.
- •5. Aged 18 - 89 years
- •6. Can tolerate behavioural and psychological testing
- •7. Score of or above 14 on the PAS
排除标准
- •General exclusion criteria
- •1. Past/present psychotic disorder, bipolar disorder/mania or alcohol/substance use disorder (outside a comorbid psychiatric episode) that would interfere in completing assessments or impair the safety of the participant.
- •2. History of medical illness that may impair cognitive function (e.g. serious head injury, endocrine disorder)
- •3. Atypical PD syndromes due to either drugs (e.g. metoclopramide, flunarizine, neuroleptics) or metabolic disorders (e.g. Wilson’s disease), encephalitis, or degenerative diseases (e.g. progressive supranuclear palsy).
- •4. Previously obtained MRI scan with evidence of clinically significant other neurological disorder (in the opinion of the Investigator).
- •MRI exclusion criteria
- •5. MRI contraindications such as a pacemaker, aneurysm clip, cochlear implant, neurostimulator, IUD, shrapnel, metal fragments in the eye, a weight of above 250lbs or claustrophobia.
- •6. There are no exclusionary medications for this study.
- •7. Females who are pregnant, planning pregnancy, or breastfeeding.
研究者
相似试验
已完成
不适用
Psychological Ressources, Anxiodepressive Symptoms, Well-being and Therapeutical Observance in Parkinson's DiseaseParkinson's DiseaseNCT05919628Central Hospital, Nancy, France25
尚未招募
不适用
The emotional response in Parkinson`s disease before and after bilateral STN stimulatioParkinson movementdisorder10028037NL-OMON30351Academisch Medisch Centrum10
终止
不适用
tDCS in Parkinson's Disease With DepressionParkinson'sDepressionNCT02315781Pacific Parkinson's Research Centre3
已完成
不适用
Apathy in patients with Parkinson*s disease and major depressive disorder, a structural brain imaging study using Voxel Based Morphometrypathological indifference1002930510027946NL-OMON30824niversiteit Maastricht120
已完成
不适用
Profile of Depressive Symptoms in Parkinsons DiseaseDepressionParkinson DiseaseNCT00349310Boehringer Ingelheim1,018
